{"SPADE_UN_29726": {"Sequence Information": {"Peptide Name": "Neocryptolepine 9(Pro)", "Sequence": "P", "Sequence Length": 1, "Biological Activity": ["Anti-Gram+", "Anti-Gram-", "Anticancer", "Antifungal", "Anti-Mammalian Cell"], "Binding Target": "1. Lipid Bilayer", "Source": "", "Gene": "", "PDB ID": "", "UniProt Entry": [], "Literature": [{"Title": "Searching for new derivatives of neocryptolepine: synthesis, antiproliferative, antimicrobial and antifungal activities.", "Pubmed ID": "24686017", "Reference": "Eur J Med Chem. 2014;78:304-313", "Author": "Sidoryk K, Jaromin A, Edward JA, Switalska M, Stefanska J, Cmoch P, Zagrodzka J, Szczepek W, Peczynska-Czoch W, Wietrzyk J, Kozubek A, Zarnowski R, Andes DR, Kaczmarek L", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/24686017"}, {"Title": "Synthesis and biological evaluation of new amino acid and dipeptide derivatives of neocryptolepine as anticancer agents.", "Pubmed ID": "22574992", "Reference": "J Med Chem. 2012;55:5077-5087", "Author": "Sidoryk K, Switalska M, Wietrzyk J, Jaromin A, Pietka-Ottlik M, Cmoch P, Szczepek W, Zagrodzka J, Kaczmarek L, Peczynska-Czoch W", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/22574992"}], "Mass": 115.13, "PI": 5.95, "Net Charge": 0, "Hydrophobicity": -1.6, "Frequent Amino Acids": "P", "Absent Amino Acids": "ACDEFGHIKLMNOQRSTUVWY", "Basic Residues": 0, "Acidic Residues": 0, "Hydrophobic Residues": 0, "Polar Residues": 1, "Positive Residues": 0, "Negative Residues": 0, "SPADE ID": "SPADE_UN_29726", "Similar Sequences": [{"SPADE_ID": "SPADE_N_00001", "Similarity": 1.0, "Sequence": "GSGVIPTISHECHMNSFQFVFTCCS"}, {"SPADE_ID": "SPADE_N_00002", "Similarity": 1.0, "Sequence": "WKSESVCTPGCVTGLLQTCFLQTITCNCKISK"}, {"SPADE_ID": "SPADE_N_00003", "Similarity": 1.0, "Sequence": "ADRGWIKTLTKDCPNVISSICAGTIITACKNCA"}], "Hemolytic Activity": "Mouse fibroblasts BALB/3T3:IC50=0.56±0.07 µM,Human erythrocytes:15% Hemolysis=300 µM", "Target Organism": "Staphylococcus aureus NCTC 4163(MIC=12.5µg/ml),Staphylococcus aureus ATCC 25923(MIC=50µg/ml),Staphylococcus aureus ATCC 6538(MIC=12.5µg/ml),Staphylococcus aureus ATCC 29213(MIC=50µg/ml),Staphylococcus epidermidis ATCC 12228(MIC=12.5µg/ml),Bacillus subtilis ATCC 6633(MIC=12.5µg/ml),Bacillus cereus ATCC 11778(MIC=50µg/ml),Enterococcus hirae ATCC 10541(MIC=100µg/ml),Micrococcus luteus ATCC 9341(MIC=6.25µg/ml),Micrococcus luteus ATCC 10240(MIC=6.25µg/ml),Candida albicans ATCC 10231(MIC=200µg/ml),Candida albicans ATCC 90028(MIC=200µg/ml),Candida albicans SN250(MIC=200µg/ml),Candida parapsilosis ATCC 22019(MIC=200µg/ml),Escherichia coli ATCC 10538(no activity data),Escherichia coli ATCC 25922(no activity data),Escherichia coli NCTC 8196(no activity data),Proteus vulgaris NCTC 4635(no activity data),Pseudomonas aeruginosa ATCC 15442(no activity data),Pseudomonas aeruginosa NCTC 6749(no activity data),Pseudomonas aeruginosa ATCC 27853(no activity data),Bordetella bronchiseptica ATCC 4617(no activity data),Human lung carcinoma A549(IC50=0.48±0.32µM),Human breast adenocarcinoma MCF-7(IC50=0.82±0.05µM),Human colon adenocarcinoma LoVo(IC50=0.81±0.12µM),Human carcinoma HeLa-KB(IC50=0.42±0.16µM)"}}}